Epsilon M&A Deal Report - Kinesis Pharma
Transaction Multiples for the Valuation of Private Companies
Venn Life Sciences Holdings / Kinesis Pharma
No EMAT :
74907
Announced Date :
22/09/2015
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Venn Life Sciences Holdings
Target :
Kinesis Pharma
Country :
Netherlands
Sector of activity :
- Laboratories > Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Laboratory Testing Services
Business Description :
Founded in 1997 by Kees Groen, Kinesis Pharma provides specialist consultancy and contract research service s around the pre-clinical and early clinical development of drug products , to accelerate...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | 
|
|
||||||
| Current |
|
Rating :
**
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Laboratory Testing Services » = 36
| Date | Acquirer | Target | Country | Multiples | See details |
| 23/09/2013 | Genus | Genetiporc | Canada | ** | 74595 |
| 12/05/2015 | Private Group led by Parquest Capital | 5 Santé | France | * | 74168 |
Source: Epsilon Research / EMAT
